Case File №
#VI-2026-0828
Amino Asylum
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
40 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | A Great | 2 | 7.8 | 7.6 | 8.0 | 14 Feb 2025 |
| CJC-1295 | C Okay | 2 | 5.6 | 4.7 | 6.6 | 19 Feb 2025 |
| BPC-157 | C Okay | 2 | 5.2 | 4.4 | 6.0 | 19 Feb 2025 |
| Retatrutide | C Okay | 2 | 5.6 | 4.8 | 6.5 | 14 Feb 2025 |
| Ipamorelin | C Okay | 2 | 5.9 | 4.2 | 7.7 | 19 Feb 2025 |
| Melanotan II | C Okay | 2 | 5.3 | 5.2 | 5.4 | 19 Feb 2025 |
| Tirzepatide | C Okay | 2 | 5.8 | 4.7 | 7.0 | 14 Feb 2025 |
| PT-141 | X Unrated | 1 | 2.5 | 2.5 | 2.5 | 16 Mar 2025 |
| 5-amino-1MQ | X N/A | 1 | 7.4 | 7.4 | 7.4 | 2 Apr 2025 |
| ACE-031 | X N/A | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 |
| AICAR Oral | X N/A | 1 | 4.0 | 2.4 | 2.4 | 13 Jun 2025 |
| AICAR | X N/A | 1 | 7.2 | 7.2 | 7.2 | 14 Jan 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 6.5 | 6.5 | 6.5 | 2 Jul 2025 |
| Botulinum toxin | X N/A | 1 | 7.4 | 7.4 | 7.4 | 7 May 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 7.2 | 7.2 | 7.2 | 13 Feb 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 6.8 | 6.8 | 6.8 | 6 May 2025 |
| CJC-1295 With DAC | X N/A | 1 | 5.7 | 5.7 | 5.7 | 28 Mar 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 5.6 | 5.6 | 5.6 | 28 Mar 2025 |
| Crystagen | X N/A | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 4.8 | 4.8 | 4.8 | 8 Jul 2025 |
| EPO | X N/A | 1 | 4.7 | 4.7 | 4.7 | 16 Mar 2025 |
| GHRP-6 Acetate | X N/A | 1 | 5.9 | 5.9 | 5.9 | 3 Jun 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 1 | 5.5 | 5.5 | 5.5 | 20 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Jun 2025 |
| KPV | X N/A | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 |
| Lipo-B 216mg | X N/A | 1 | 4.7 | 4.7 | 4.7 | 11 Jun 2025 |
| Lipo-C 120mg | X N/A | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 |
| MOTS-C | X N/A | 1 | 5.8 | 5.8 | 5.8 | 7 May 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 7.5 | 7.5 | 7.5 | 7 May 2025 |
| Orforglipron | X N/A | 1 | 5.4 | 5.4 | 5.4 | 3 Jul 2025 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | X N/A | 1 | 5.0 | 5.0 | 5.0 | 16 Mar 2025 |
| Phenylacetic acid CAS 103-82-2 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 2 Apr 2025 |
| Pinealon | X N/A | 1 | 6.3 | 6.3 | 6.3 | 7 May 2025 |
| Prostamax | X N/A | 1 | 5.2 | 5.2 | 5.2 | 3 Jul 2025 |
| Retatrutide Raw | X N/A | 1 | 4.5 | 4.5 | 4.5 | 13 Jun 2025 |
| Semaglutide Oral | X N/A | 1 | 4.7 | 4.7 | 4.7 | 28 Mar 2025 |
| Sustanon Blend Raw | X N/A | 1 | 4.0 | 3.9 | 3.9 | 28 Mar 2025 |
| T3 (Liothyronine) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 2 Jul 2025 |
| Vilon | X N/A | 1 | 5.4 | 5.4 | 5.4 | 14 Jan 2025 |
| Winstrol Oil | X N/A | 1 | 4.9 | 4.9 | 4.9 | 11 Jun 2025 |
Exhibit II
Evidence Log
39 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | 5-amino-1MQ | 8.4 A | 30mg | 35.4mg | +18.0% | 97.38% | acjt8z | Lab C | Public |
| 24 May 2026 | BPC157 10mg + TB500 10mg Blend | 7.6 A | 5mg | 6.1mg | +21.3% | 97.14% | vgi2r2 | Lab E | Public |
| 24 May 2026 | Botulinum toxin | 6.9 A | 20mg | 17.4mg | -12.9% | 95.95% | re0if1 | Lab E | Public |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.2 C | 30mg | 30.8mg | +2.6% | 98.11% | 8sak69 | Lab C | Public |
| 24 May 2026 | CJC-1295 With DAC | 4.4 C | 15mg | 15.6mg | +3.7% | 99.39% | a7kgbo | Lab G | Public |
| 24 May 2026 | Phenylacetic acid CAS 103-82-2 | 6.5 A | 100g | 94.9g | -5.1% | 97.13% | 1sj6uu | Lab B | Public |
| 24 May 2026 | AICAR | 6.0 A | 30mg | 25.7mg | -14.2% | 98.27% | r67fcx | Lab F | Public |
| 23 May 2026 | KPV | 4.0 C | 50mg | 59.6mg | +19.2% | 96.75% | xonr0c | Lab A | Public |
| 20 May 2026 | Orforglipron | 5.4 B | 50mg | 42.6mg | -14.7% | 98.56% | rb3b42 | Lab C | Public |
| 20 May 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 4.2 C | 5g | 4.9g | -1.2% | 99.33% | zya1mf | Lab B | Public |
| 20 May 2026 | T3 (Liothyronine) | 5.1 B | 10mg | 8.8mg | -12.1% | 99.10% | opqzqv | Lab B | Community |
| 20 May 2026 | Winstrol Oil | 4.6 C | 300mg/ml | 310.5mg/ml | +3.5% | 98.74% | 0y32ak | Lab E | Public |
| 19 May 2026 | N-Acetyl Epitalon Amidate | 7.9 A | 20mg | 22.1mg | +10.4% | 96.67% | bbd5hr | Lab D | Public |
| 29 Jan 2026 | Crystagen | 10.0 A | 10mg | 11.7mg | +16.7% | 99.20% | zgh2uh | Lab F | Public |
| 26 Jan 2026 | Aromasin (Exemestane) | 4.6 C | 50mg | 52.3mg | +4.6% | 99.71% | m5d6xb | Lab E | Community |
| 19 Jan 2026 | Vilon | 5.2 B | 10mg | 12.5mg | +24.5% | 97.14% | 38o7z0 | Lab D | Community |
| 9 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 9.1 A | 15mg | 13.4mg | -10.7% | 97.07% | at3t5e | Lab F | Public |
| 7 Jan 2026 | Drostanolone Enanthate (Mast E) Raw | 5.3 B | 5g | 5.0g | -0.3% | 98.11% | 1m2mk6 | Lab G | Public |
| 6 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.6 B | 30mg | 29.3mg | -2.3% | 98.11% | xftzon | Lab A | Community |
| 29 Dec 2025 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 6.7 A | 2mg | 1.7mg | -14.8% | 98.23% | snot8t | Lab C | Public |
| 12 Dec 2025 | AICAR Oral | 4.4 C | 20mg | 24.2mg | +21.1% | 98.65% | x2h800 | Lab E | Community |
| 12 Dec 2025 | EPO | 5.1 B | 30mg | 30.6mg | +1.9% | 97.21% | kjgyb9 | Lab F | Community |
| 12 Dec 2025 | Prostamax | 5.6 B | 15mg | 18.4mg | +22.5% | 98.97% | viceb0 | Lab C | Public |
| 5 Dec 2025 | Lipo-B 216mg | 4.3 C | 100mg/ml | 95.3mg/ml | -4.7% | 95.28% | 38t9eb | Lab F | Community |
| 17 Nov 2025 | MOTS-C | 5.7 B | 30mg | 28.5mg | -4.9% | 97.00% | s1flyl | Lab B | Public |
| 14 Nov 2025 | GHRP-6 Acetate | 4.3 C | 50mg | 45.3mg | -9.3% | 97.05% | ofqchi | Lab C | Community |
| 5 Nov 2025 | ACE-031 | 5.7 B | 30mg | 34.8mg | +16.2% | 99.35% | tfap96 | Lab D | Community |
| 5 Nov 2025 | Lipo-C 120mg | 6.9 A | 100mg/ml | 115.8mg/ml | +15.8% | 98.69% | vqybeh | Lab F | Community |
| 5 Nov 2025 | Semaglutide Oral | 4.9 C | 25mg | 21.9mg | -12.5% | 95.72% | 0k8yd4 | Lab D | Community |
| 4 Nov 2025 | Pinealon | 8.7 A | 2mg | 2.4mg | +21.8% | 95.81% | puvtjz | Lab F | Public |
| 4 Nov 2025 | Retatrutide Raw | 4.8 C | 5g | 5.0g | +0.2% | 95.50% | oa8gzb | Lab G | Community |
| 4 Nov 2025 | Sustanon Blend Raw | 4.0 C | 100g | 93.2g | -6.8% | 96.77% | hobhya | Lab G | Public |
| 16 Mar 2025 | PT-141 | X | 2.5 | 10mg | 8.08mg | -19.2% | 98.40% | White Label / Silver Crimp / Blue Cap | Lab A |
| 21 Feb 2025 | CJC-1295 | No DAC X | 6.6 | 2mg | 2.03mg | +1.5% | 99.29% | White Label / Silver Crimp / Red Cap | Lab B |
| 19 Feb 2025 | Melanotan II | X | 5.4 | 10mg | 11.14mg | +11.4% | 99.58% | White Label / Silver Crimp / Red Cap | Lab A |
| 19 Feb 2025 | BPC-157 | X | 4.4 | 5mg | 8.34mg | +66.8% | 100.00% | White Label / Silver Crimp / Violet Cap | Lab B |
| 19 Feb 2025 | Retatrutide | X | 6.5 | 5mg | 5.45mg | +9.0% | 99.80% | White Label / Silver Crimp / Green Cap | Lab B |
| 19 Feb 2025 | Ipamorelin | X | 7.7 | 2mg | 1.99mg | -0.5% | 99.78% | White Label / Silver Crimp / Pink Cap | Lab A |
| 19 Feb 2025 | Semaglutide | X | 7.6 | 5mg | 5.15mg | +3.0% | 99.74% | White Label / Silver Crimp / Blue Cap | Lab B |
— END OF EVIDENCE LOG —